Company news

Telesta Therapeutics Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Telesta Therapeutics Inc. announces closing of arrangement with Prometic Life Sciences Inc.

October 31, 2016

Telesta Therapeutics Inc. announces final court approval of plan of arrangement with ProMetic Life Sciences Inc.

October 28, 2016

Telesta Therapeutics Inc. shareholders approve plan of arrangement with ProMetic Life Sciences Inc.

October 25, 2016

Leading Independent Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Plan of Arrangement between Telesta Therapeutics Inc. and ProMetic Life Sciences Inc.

October 11, 2016

Telesta Therapeutics Publishes its Annual Financial Statements and Provides Date of Special Shareholders Meeting

September 19, 2016

Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc.

August 24, 2016

Telesta Therapeutics Provides Strategic Update

August 2, 2016

Telesta Therapeutics Publishes its Q3, 2016 Financial Statements and Provides Corporate Updates

May 10, 2016

Telesta Announces Type A Meeting Results and Strategic Option Review

April 18, 2016

Telesta Therapeutics Corporate Update - Type A Meeting with the FDA Scheduled

April 12, 2016

Telesta Therapeutics Provides Corporate Update

March 9, 2016

Telesta Therapeutics Publishes its Q2, 2016 Financial Statements and Provides Corporate Updates

February 12, 2016

Telesta Therapeutics Receives Complete Response Letter from FDA

February 2, 2016

Telesta Therapeutics Corporate Update

December 14, 2015

Telesta Therapeutics Announces Results of the FDA Advisory Committee Vote

November 19, 2015

Telesta Therapeutics Inc. Announces Results of Annual General Meeting of Shareholders

November 16, 2015

Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates

November 12, 2015

Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories

October 28, 2015

Telesta Therapeutics Appoints Brian J. Groch as Chief Commercial Officer

October 8, 2015

Telesta Announces FDA Advisory Committee Date for MCNA1

September 28, 2015

Telesta Therapeutics Publishes its Annual Consolidated Financial Statements and Provides Corporate Updates

September 14, 2015

Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)

August 28, 2015

Telesta Therapeutics Closes US$28.6 Million Private Placement

August 19, 2015

Telesta Therapeutics Announces South Korean Partnership for MCNA & Concurrent Private Placement

July 20, 2015

Telesta Therapeutics Submits Biologics License Application (BLA) to the U.S. FDA

June 30, 2015

Telesta Therapeutics Announces Issuance of Key U.S. MCNA Composition of Matter Patent

June 3, 2015

Telesta Therapeutics Publishes its Nine Month Financial Results to March 31, 2015 and Provides Corporate Updates

May 14, 2015

Telesta Therapeutics Provides Key Corporate Updates

April 27, 2015

Telesta Therapeutics Publishes its 6 Month Financial Results to December 31, 2014 and Provides Important Corporate Updates

February 13, 2015

Telesta Therapeutics Announces Key Clinical & Corporate Updates

December 1, 2014

Bioniche Life Sciences Inc. Rebrands as Telesta Therapeutics Inc.

November 24, 2014

Investment Industry Regulatory Organization of Canada - Trade Resumption - Bioniche Life Sciences Inc. - BNC

November 22, 2010

Investment Industry Regulatory Organization of Canada - Trading Halt - Bioniche Life Sciences Inc. - BNC

November 22, 2010

Investment Industry Regulatory Organization of Canada - Trading Halt - Bioniche Life Sciences Inc - BNC

September 27, 2010

Investment Industry Regulatory Organization of Canada - Trade Resumption - Bioniche Life Sciences Inc. - BNC

April 19, 2010

Investment Industry Regulatory Organization of Canada - Trade Resumption - Bioniche Life Sciences Inc. - BNC

February 12, 2010

Investment Industry Regulatory Organization of Canada - Trading Halt - Bioniche Life - BNC

February 12, 2010